CONGRESS 2014

Program & Downloads

Click here to download the program

Read articles from Liver International

Watch the videos of the conference

Press review

Click here to view the speakers list

HEPATITIS C - Monday, January 13th 2014

  • 08:30 Introduction: Treatment of hepatitis C: soon the end of the road ? - Patrick MARCELLIN (France)
  • 08:45 - 09:15 State of the art lecture and Award - Chairman: Tarik ASSELAH (France)
  • 09:15 - 10:30 How to optimize current therapy of G1 patients - Chairpersons: Ira JACOBSON (USA) Masao OMATA (Japan)
  • 09:15 Personalized treatment with telaprevir - Graham FOSTER (UK)
  • 09:30 Personalized treatment with boceprevir - Marc BOURLIERE (France)
  • 09:45 Is there still a role for PEG IFN+RBV therapy? - Lawrence SERFATY (France)
  • 10:00 Round table discussion
  • 10:30 - 11:00 Coffee break
  • 11:45 Round table discussion
  • 12:00 - 12:30 State of the art lecture and Award - Chairman: Patrick MARCELLIN (France)
  • 15:15 Round table discussion
  • 15:45 - 16:00 Coffee break
  • 16:00 Advantages of 2nd generation triple therapy - Tarik ASSELAH (France)
  • 16:15 Protease, polymerase and NS5A inhibitors: what will be the wining combination? - Raymond SCHINAZI (USA)
  • 16:45 Round table discussion
  • 18:00 Ajournement
  • 19:30 Congress dinner

HEPATITIS B - Tuesday, January 14th 2014

  • 08:30 Introduction: HBV: Who, when and how to treat? - Chairman: Patrick MARCELLIN (France)
  • 08:40 - 10:00 The control of HBV related liver disease - Chairpersons: Henry CHAN (Hong Kong) Fabien ZOULIM (France)
  • 08:40 Regression of fibrosis. Is cirrhosis reversible? - Antonio CRAXI (Italy)
  • 08:55 Are non-invasive markers of fibrosis reliable? - Laurent CASTERA (France)
  • 09:10 HBsAg quantitation : useful for staging the liver disease? - Maurizia BRUNETTO (Italy)
  • 09:40 Round table discussion
  • 10:00 - 10:30 Coffee break
  • 10:30 - 11:30 Optimal therapy of HBeAg-positive chronic hepatitis B - Chairpersons: Ji Dong JIA (China) Michael FRIED (USA)
  • 10:45 Why do I treat my patient with pegylated IFN? - Jia-Horng KAO (Taiwan)
  • 11:00 Round table discussion
  • 12:00 Round table discussion
  • 14:30 New interferons and immunomodulators - Jake LIANG (USA)
  • 14:45 Impact of HBV therapy on the incidence of hepatocellular carcinoma - Massimo COLOMBO (Italy)
  • 15:15 Round table discussion
  • 16:00 Ajournement